Stockysis — AI-Powered Stock News & Sentiment Analysis

Needham Upgrades Hims & Hers Health to Buy, Announces $30 Price Target

Benzinga Newsdesk www.benzinga.com Positive 51.8%

Neg 0% Neu 0% Pos 51.8%

Needham analyst Ryan MacDonald upgrades Hims & Hers Health (NYSE:HIMS) from Hold to Buy and announces $30 price target.

Comments

No comments yet. Be the first!